UPDATE: Cantor Fitzgerald Starts Cassava Sciences (SAVA) at Overweight, Bullish on Drug for Alzheimer's and Other Neurodegenerative Diseases
Tweet Send to a Friend
(Updated - October 23, 2020 6:40 AM EDT)
(updated to add analyst comments)Cantor Fitzgerald analyst Charles C. Duncan initiates ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comments)Cantor Fitzgerald analyst Charles C. Duncan initiates ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
